CureSureMedico
Currency

Ocular & Eye Cancer Treatment

Oncology

payments

Starting from

$3,000

Up to $20,000 depending on centre

schedule

Typical duration

7–21 days

Including pre-operative work-up

medical_services

Procedures

3

Hold to see procedures

arrow_downwardlocal_hospital

Partner hospitals

0

Vetted for outcome data & accreditation

Overview

Highly specialised ocular oncology for uveal melanoma, retinoblastoma, conjunctival tumours, and orbital malignancies — connecting patients with experienced oculo-oncology teams that combine vision-preservation techniques with rigorous cancer control.

Your case is matched to a centre on the basis of clinical outcome data, not marketing. We coordinate every step — from pre-operative work-up to post-treatment follow-up — with a dedicated care coordinator.

What's included

Ophthalmic oncology assessment — ultrasound biomicroscopy, fundus photography & MRI orbit
Tumour board review with ocular oncologist & radiation oncologist
Treatment procedure & hospitalisation
Ocular oncologist & surgical team fees
Interpreter & care coordinator
Systemic metastatic surveillance plan & follow-up at home

Coordinated from

$3,000

or message us on WhatsApp

No commitment required. Your data is never shared with third parties.

Global cost comparison — Ocular & Eye Cancer Treatment

Average coordinated costs across our partner centres. Final pricing depends on clinical complexity and chosen hospital.

CountryAvg. cost
🇮🇳

India

New Delhi · Chennai · Bengaluru · Hyderabad · Mumbai · Kochi

Best value
$5,000
🇹🇷

Turkey

Istanbul

$12,000

Costs are indicative and reviewed quarterly. Request a personalised estimate for your specific case.

Frequently asked questions

In many cases, yes. Episcleral plaque brachytherapy is the standard vision-sparing treatment for uveal (choroidal) melanoma tumours up to a certain thickness and diameter, achieving local control rates above 90% while preserving the eye. For retinoblastoma in children, intra-arterial chemotherapy and laser photocoagulation have transformed outcomes, avoiding enucleation in a significant proportion of cases. Suitability for eye-preserving treatment depends on tumour size, location, and involvement of critical structures.

No fees. No commitment.

Our guidance is completely free

We are compensated by our partner hospitals — never by patients. You get independent clinical matching, cost transparency, and end-to-end coordination at no cost to you.

Message us on WhatsApp